VCIM
INBX

Velan Capital Investment Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Velan Capital Investment Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-25,000
Closed -$459K – 35
2023
Q3 		$459K Hold
25,000
– – 0.37% 28
2023
Q2 		$649K Buy
+25,000
New +$584K 0.6% 28

Other funds holding INBX

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Velan Capital Investment Management's INBX Position: Q4 2023 in Review

Velan Capital Investment Management sold out of Inhibrx, Inc. Common Stock (INBX) in Q4 2023, closing a stake of 25,000 shares — an estimated $459K sold.

Velan Capital Investment Management first reported a position in INBX in Q2 2023 and held it in 2 quarters. The position peaked at $649K in Q2 2023. 127 funds tracked by Wall St. Rank hold INBX as of Q4 2023.

  • Velan Capital Investment Management reported no remaining Inhibrx, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Velan Capital Investment Management sold 25,000 Inhibrx, Inc. Common Stock shares in Q4 2023, an estimated $459K.
  • Velan Capital Investment Management first reported a position in Inhibrx, Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • Velan Capital Investment Management's Inhibrx, Inc. Common Stock position peaked at $649K in Q2 2023.
  • 127 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q4 2023.

Based on Velan Capital Investment Management's 13F filing for Q4 2023, filed 14 Feb 2024.